Clinical trial
Donor Stem Cell Transplant in Treating Young Patients With Relapsed or…
NCT00112645 · Milton S. Hershey Medical Center, Other · Completed
Key facts
| NCT number | NCT00112645 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors |
| Official title | A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Pediatric Solid Tumors With Relapsed or Therapy Refractory Disease |
| Lead sponsor | Milton S. Hershey Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug, Procedure |
| Interventions | anti-thymocyte globulin, busulfan, cyclosporine, melphalan, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation, umbilical cord blood transplantation |
| Enrollment | 10 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Jun 3, 2005 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: